capillary blood collection for vulnerable patient populations
Venipuncture is painful. It's frightening. When you're performing research with, or delivering healthcare to, vulnerable patient populations, it can pose a significant impediment.
Traditional blood draws are particularly unpleasant for children - pediatric patients can't fully understand what's going on. With elderly patients, the very ill, or those in low-resourced regions, other difficulties can arise, such as the inability to make long-distance visits to clinics for blood draws.
The most vulnerable patient populations - elderly patients, children, those in low-resourced regions, and others - tend to have the most significant difficulties with venipuncture.
Working with capillary blood in these contexts can potentially make things easier. However, older methods of dried capillary blood collection, such as dried blood spot (DBS) cards and filter paper, suffer from limitations (most notably the hematocrit bias) cramping their ability to get specimens that can in turn generate high-quality data of the sort that is needed to better serve vulnerable populations in healthcare.
Enter Volumetric Absorptive Microsampling (VAMS®) technology, the better dried blood collection system behind the breakthrough Mitra® device. VAMS® is making capillary blood collection easier for vulnerable patient populations and, for pediatric patients, much less intimating.
Because anyone can collect their own samples with minimal training, VAMS® is energizing work with vulnerable populations. Clinical research, clinical trials, and other crucial, lifesaving work has become easier as this smarter blood collection technology has begun to proliferate.
The researchers who work with the most vulnerable populations often lead the way in patient-centered care. Already, Mitra® devices have enabled research on blood biomarkers for malnutrition in Liberia. They've allowed organ transplant patients to climb mountains. And they've made life easier for pediatric transplant patients, their physicians, and their parents. It's no wonder that 93% of patients consider themselves "likely" or "very likely" to choose VAMS® over any other method of blood collection when it comes to patients from the most vulnerable populations.
It's time to make your work more patient-centered. Better blood collection matters. Neoteryx is the blood microsampling innovator. Read our white paper to learn more, or contact a Microsampling Specialist today to get started.